Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1997 2
1999 1
2000 1
2001 1
2002 2
2003 1
2005 2
2006 6
2007 2
2009 2
2010 7
2011 11
2012 24
2013 11
2014 8
2015 7
2016 5
2017 4
2018 2
2019 3
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 23390018

96 results

Results by year

Filters applied: . Clear all
Page 1
Biosimilars in rheumatology: the wind of change.
Schneider CK. Schneider CK. Ann Rheum Dis. 2013 Mar;72(3):315-8. doi: 10.1136/annrheumdis-2012-202941. Ann Rheum Dis. 2013. PMID: 23390018 Free article. No abstract available.
European perspective on biosimilars.
Wadhwa M, Thorpe R. Wadhwa M, et al. Bioanalysis. 2013 Mar;5(5):521-4. doi: 10.4155/bio.13.2. Bioanalysis. 2013. PMID: 23425266 No abstract available.
Biosimilars in rheumatology: perspective and concerns.
Scheinberg MA, Azevedo VF. Scheinberg MA, et al. Rheumatology (Oxford). 2014 Mar;53(3):389-90. doi: 10.1093/rheumatology/ket210. Epub 2013 Jul 22. Rheumatology (Oxford). 2014. PMID: 23878310 No abstract available.
Biosimilars take center stage.
Adams KT. Adams KT. Manag Care. 2014 Apr;23(4):44-6. Manag Care. 2014. PMID: 24864533 No abstract available.
Competition in the Age of Biosimilars.
Chandra A, Vanderpuye-Orgle J. Chandra A, et al. JAMA. 2015 Jul 21;314(3):225-6. doi: 10.1001/jama.2015.6170. JAMA. 2015. PMID: 26197179 No abstract available.
Mini Focus: bioanalysis of biosimilars.
Amaravadi L, Marini J. Amaravadi L, et al. Bioanalysis. 2013 Mar;5(5):515-6. doi: 10.4155/bio.13.26. Bioanalysis. 2013. PMID: 23425264 Free article. No abstract available.
Key considerations in the preclinical development of biosimilars.
Bui LA, Hurst S, Finch GL, Ingram B, Jacobs IA, Kirchhoff CF, Ng CK, Ryan AM. Bui LA, et al. Drug Discov Today. 2015 May;20 Suppl 1:3-15. doi: 10.1016/j.drudis.2015.03.011. Epub 2015 Apr 23. Drug Discov Today. 2015. PMID: 25912284 Review.
96 results